Search Results - "Grill, Joshua"

Refine Results
  1. 1

    The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA by Karlawish, Jason, Grill, Joshua D.

    Published in Nature reviews. Neurology (01-09-2021)
    “…The FDA has granted accelerated approval to aducanumab (Aduhelm) for the treatment of Alzheimer disease with an overly broad label. The decision disregarded…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials by Grill, Joshua D., Karlawish, Jason

    Published in Neurology (07-09-2021)
    “…The goal of clinical research is to improve clinical practice. In progressive neurodegenerative conditions without any disease-slowing therapies, this will…”
    Get full text
    Journal Article
  5. 5

    Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum by Largent, Emily A., Grill, Joshua D., O'Brien, Kyra, Wolk, David, Harkins, Kristin, Karlawish, Jason

    Published in Neurology (23-05-2023)
    “…Three pathologic processes are characteristic of Alzheimer disease (AD)β-amyloid, hyperphosphorylated tau, and neurodegeneration. Our understanding of AD is…”
    Get full text
    Journal Article
  6. 6

    Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials by Grill, Joshua D, Karlawish, Jason

    Published in Alzheimer's research & therapy (21-12-2010)
    “…Among the key challenges in Alzheimer's disease drug development is the timely completion of clinical trials. Unfortunately, clinical trials often suffer from…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer’s disease clinical trials by Grill, Joshua, PhD, Zhou, Yan, PhD, Elashoff, David, PhD, Karlawish, Jason, MD

    Published in Neurobiology of aging (01-03-2016)
    “…Abstract Preclinical Alzheimer’s disease (AD) clinical trials may require participants to learn if they meet biomarker enrollment criteria to enroll. To…”
    Get full text
    Journal Article
  10. 10

    Alzheimer's disease biomarkers and the tyranny of treatment by Karlawish, Jason, Grill, Joshua D.

    Published in EBioMedicine (01-10-2024)
    “…Advances in treatment are changing not only the therapeutic options for patients with Alzheimer's disease; they're also changing their diagnostic options…”
    Get full text
    Journal Article
  11. 11

    Frameworks for estimating causal effects in observational settings: comparing confounder adjustment and instrumental variables by Zawadzki, Roy S, Grill, Joshua D, Gillen, Daniel L

    Published in BMC medical research methodology (22-05-2023)
    “…To estimate causal effects, analysts performing observational studies in health settings utilize several strategies to mitigate bias due to confounding by…”
    Get full text
    Journal Article
  12. 12

    Direct Mail Recruitment to a Potential Participant Registry by Gombosev, Adrijana, Salazar, Christian R., Hoang, Dan, Cox, Chelsea G., Gillen, Daniel L., Grill, Joshua D.

    Published in Alzheimer disease and associated disorders (01-01-2021)
    “…Recruitment registries are novel tools to accelerate Alzheimer disease research accrual. Optimal methods to populate such registries remain largely unstudied…”
    Get full text
    Journal Article
  13. 13

    Facilitating Alzheimer Disease Research Recruitment by Grill, Joshua D., Galvin, James E.

    Published in Alzheimer disease and associated disorders (01-01-2014)
    “…Alzheimer disease (AD) research faces challenges to successful enrollment, especially to clinical trials and biomarker studies. Failure to recruit the planned…”
    Get full text
    Journal Article
  14. 14

    Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment by Grill, Joshua D, Raman, Rema, Ernstrom, Karin, Sultzer, David L, Burns, Jeffrey M, Donohue, Michael C, Johnson, Keith A, Aisen, Paul S, Sperling, Reisa A, Karlawish, Jason

    Published in JAMA neurology (01-12-2020)
    “…The goal of preclinical Alzheimer disease (AD) clinical trials is to move diagnosis and treatment to presymptomatic stages, which will require biomarker…”
    Get more information
    Journal Article
  15. 15

    Post‐disclosure distress among racial and ethnic groups in a preclinical AD trial by Ritchie, Marina, Salazar, Christian R., Gillen, Daniel L., Grill, Joshua D.

    Published in Alzheimer's & dementia (01-04-2024)
    “…INTRODUCTION Trialists need a thorough understanding of whether reactions to Alzheimer's disease (AD) biomarker information differ among racial and ethnic…”
    Get full text
    Journal Article
  16. 16

    Retention of American Indian and Alaska Native participants in the National Alzheimer's Coordinating Center Uniform Data Set by Conniff, Kyle R, Grill, Joshua D, Gillen, Daniel L

    Published in Alzheimer's & dementia (01-03-2024)
    “…The number of American Indian and Alaska Native (AI/AN) elders is expected to double by 2060. Thus it is imperative to retain AI/AN participants in…”
    Get full text
    Journal Article
  17. 17

    Economic hardships of Korean American family caregivers of persons with dementia: a mixed-methods study by Lee, Kathy, Seo, Chang Hyun, Cassidy, Jessica, Shin, Hye-Won, Grill, Joshua D.

    Published in Aging & mental health (02-09-2023)
    “…Objectives. This study examined the relationships between economic hardships (i.e. perceived financial hardship and job interference) and caregiver burden…”
    Get full text
    Journal Article
  18. 18

    Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial by Raman, Rema, Quiroz, Yakeel T, Langford, Oliver, Choi, Jiyoon, Ritchie, Marina, Baumgartner, Morgan, Rentz, Dorene, Aggarwal, Neelum T, Aisen, Paul, Sperling, Reisa, Grill, Joshua D

    Published in JAMA network open (06-07-2021)
    “…Underrepresentation of many racial/ethnic groups in Alzheimer disease (AD) clinical trials limits generalizability of results and hinders opportunities to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Examining Utilization of Formal Supports and Related Impacts on Overall Well-Being Among East Asian American Family Caregivers of Persons With Dementia: A Mixed-Methods Study by Lee, Kathy, Cassidy, Jessica, Lee, Jihui, Seo, Chang Hyun, Kunz Lomelin, Alan, Shin, Hye-Won, Grill, Joshua D

    Published in The Gerontologist (01-02-2024)
    “…Abstract Background and Objectives Although East Asian American family caregivers are known to underutilize formal support services, there is a lack of…”
    Get full text
    Journal Article